Found: 3
Select item for more details and to access through your institution.
Mepirapim, a novel synthetic cannabinoid, induces Parkinson's disease-related behaviors by causing maladaptation of the dopamine system in the brain.
- Published in:
- Archives of Toxicology, 2023, v. 97, n. 2, p. 581, doi. 10.1007/s00204-022-03414-y
- By:
- Publication type:
- Article
Mosloflavone-Resveratrol Hybrid TMS-HDMF-5z Exhibits Potent In Vitro and In Vivo Anti-Inflammatory Effects Through NF-κB, AP-1, and JAK/STAT Inactivation.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.857789
- By:
- Publication type:
- Article
Mepirapim, a Novel Synthetic Cannabinoid, Induces Addiction-Related Behaviors through Neurochemical Maladaptation in the Brain of Rodents.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 6, p. 710, doi. 10.3390/ph15060710
- By:
- Publication type:
- Article